診断上の課題:ディストニアとパーキンソン症候群を伴う脊髄小胞性アタキア6型
Tal Jonatan Koren1, Kate E Ahmad2, Kishore R Kumar3,4
1Department of Neurology, Royal North Shore Hospital, St Leonards, New South Wales, Australia taljkoren@gmail.com.
BMJ case reports
|August 22, 2025
まとめ
脊髄小胞性アタキシア6型 (SCA6) は,小胞性でない症状で診断が難しい. この症例は 成人の発症神経変性疾患の 広範な表型を強調しています
科学分野:
- 神経科学
- 遺伝学
- 神経科学
背景:
- スピノセレベラアタキア (SCA) は,自己相支配性であり,成人期に発症する神経変性疾患である.
- SCA6は典型的には"純粋な小脳性"アタキシアと考えられ,歩行アタキシア,ニスタグムス,および不発症によって特徴付けられます.
- しかし,小脳外症状が発生し,臨床的状況が複雑になる可能性があります.
研究 の 目的:
- スピノセレベラアタキシアタイプ6 (SCA6) の症例を提示する.
- 異常なSCA6の提示によって引き起こされる診断上の課題を強調する.
- SCA6現象型のより広い理解のために文献をレビューする.
主な方法:
- 70代で 運動障害の症状がある患者の報告です
- 硬直性,ディストニア,コントラクトゥール,ディサルトリア,眼球障害,筋肉縮の評価を含む臨床評価
- 遺伝的原因を特定するために エクソムの配列を解析する
主要な成果:
- 硬直性やジストニアを含む,大きな非小脳症候群を呈した.
- 全エクソーム配列解析により,SCA6を確認した *CACNA1A* 遺伝子の22のCAG繰り返しが明らかになった.
- 文献のレビューは,純粋に小脳症状を超えて,SCA6のより広範な表型を支持した.
結論:
- SCA6は,パーキンソン病やディストニアを含む,多種多様な非小脳特性を表すことができます.
- 遺伝子検査,特に*CACNA1A*遺伝子解析は,非典型のSCA6症例の診断に不可欠です.
- SCA6の拡張型を認識することは,正確な診断と患者の管理に不可欠です.
関連する概念動画
Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703
Parkinson's Disease: Treatment
377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Neural Regulation
39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K
REM Sleep Behavior Disorder
400
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
400
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K


